MASI
Masimo Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$179.95
+0.00%Year over year
Reported trailing growth
- Revenue
- -14.4%
- EBITDA
- +414.9%
- EBIT
- +248.0%
- EPS
- +115.6%
- Free cash flow
- +52.2%
- Operating cash flow
- +27.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.1%
- EBITDA
- -1.0%
- EBIT
- +14.2%
- Net income
- +50.3%
- EPS
- +50.5%
- Free cash flow
- +455.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Apr 1, 2026